Cargando…

Genetic Testing in Evaluating Risk of Anthracycline Cardiomyopathy: Are We There Yet?

Detalles Bibliográficos
Autores principales:	Wong-Siegel, Jeannette R., Kim, Yuri, Stitziel, Nathan O., Javaheri, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308055/ https://www.ncbi.nlm.nih.gov/pubmed/37397085 http://dx.doi.org/10.1016/j.jaccao.2023.02.003

Ejemplares similares

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

Paediatric HIV: we are not done yet!
por: Penazzato, Martina
Publicado: (2020)

Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV
por: Vreeman, Rachel C, et al.
Publicado: (2021)

Precision Medicine for Breath-Focused Mind-Body Therapies for Stress and Anxiety: Are We Ready Yet?
por: Lavretsky, Helen, et al.
Publicado: (2021)

Detecting and Targeting Inflammation in Genetic Cardiomyopathies: Are We There Yet?
por: Pinney, Sean P., et al.
Publicado: (2023)

Are we there yet? The transition from response to recovery for the COVID-19 pandemic
por: Fakhruddin, Bapon (SHM), et al.
Publicado: (2020)

Structure versus function: Are new conformations of pannexin 1 yet to be resolved?
por: Mim, Carsten, et al.
Publicado: (2021)

Why Biological Psychiatry Hasn’t Delivered Yet – and Why Neurology Knows
por: Frisch, Stefan
Publicado: (2021)

Coxitis in axial spondyloarthritis: the unmeasured, yet functionally most important, radiographic progression
por: Rocha, Francisco Airton Castro, et al.
Publicado: (2021)

The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care?
por: Beil, Michael, et al.
Publicado: (2021)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Blood eosinophil level to predict chronic obstructive pulmonary disease clinical outcomes: not ready yet
por: Cai, Cheng-Sen, et al.
Publicado: (2019)

Complementary yet distinct roles for oestrogen receptor-α and oestrogen receptor-β in mouse mammary epithelial proliferation
por: Clarke, Robert B
Publicado: (2004)

Optimizing RV lead position in RV cardiomyopathy: Are we there yet?
por: Sharma, Apurva, et al.
Publicado: (2019)

Viewpoint | European COVID-19 exit strategy for people with severe mental disorders: Too little, but not yet too late
por: De Picker, Livia J., et al.
Publicado: (2021)

Quality standards and samples in genetic testing
por: Ravine, David, et al.
Publicado: (2012)

Limitations in the Diagnosis of Noncompaction Cardiomyopathy by Echocardiography
por: Hotta, Viviane Tiemi, et al.
Publicado: (2017)

Is Human Immunodeficiency Virus Infection a Risk Factor for Strongyloides stercoralis Hyperinfection and Dissemination
por: Siegel, Marc O., et al.
Publicado: (2012)

The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice
por: Forzano, Francesca, et al.
Publicado: (2021)

How much diagnostic safety can we afford, and how should we decide? A health economics perspective
por: Newman-Toker, David E, et al.
Publicado: (2013)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

Management of Amyloid Cardiomyopathy in Resource-Constrained Settings: Challenges and Opportunities
por: Singh, Suvir, et al.
Publicado: (2021)

Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it
por: Ahmad, Faheem A., et al.
Publicado: (2019)

Were we prepared for PrEP? Five years of implementation
por: Weinstein, Michael, et al.
Publicado: (2017)

Systems Cytogenomics: Are We Ready Yet?
por: Iourov, Ivan Y., et al.
Publicado: (2021)

Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?
por: Roopnarain, Karisha, et al.
Publicado: (2023)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
por: Wong-Siegel, Jeannette R., et al.
Publicado: (2023)

Are We Sure We Fully Understand What an Infodemic Is? A Global Perspective on Infodemiological Problems
por: Rovetta, Alessandro, et al.
Publicado: (2022)

Evaluation of low gradient severe aortic stenosis: should we change our outlook in the analysis of clinical data?
por: Corazza, Ivan, et al.
Publicado: (2021)

Improving responses to safety incidents: we need to talk about justice
por: Cribb, Alan, et al.
Publicado: (2022)

Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
por: Desai, Lajja, et al.
Publicado: (2019)

The rise of point-of-care genetics: how the SARS-CoV-2 pandemic will accelerate adoption of genetic testing in the acute setting
por: McDermott, John H., et al.
Publicado: (2021)

Online Health Behavior and Disease Management Programs: Are We Ready for Them? Are They Ready for Us?
por: Evers, Kerry E, et al.
Publicado: (2005)

Should We Use an Orphan Graft?
por: Baskıran, A., et al.
Publicado: (2017)

One year after the COVID-19: What have we learnt, what shall we do next?
por: Gorwood, Philip, et al.
Publicado: (2021)

The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies
por: de Boer, Rudolf A, et al.
Publicado: (2023)

Direct-to-Consumer Genetic Ancestry Testing in Clinical Encounters: Perspectives From Psychotherapy Cases
por: Rubanovich, Caryn Kseniya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2g9sv7on9uaj95cqdgqpjdaqvq